UNSP Q3/2010 Result.....

UNSP Q3/2010 Result.....

Performance UNSP pada Q3 jauh lebih baik dibanding Q2.

Operating profit membaik:
- Q1 vs Q2 vs Q3 = 151 vs 181 vs 235
- Akibatnya ratio CLOP membaik dari 19,3 pada Q2 menjadi 11,49
- Padahal harga saat ini 360 hampir sama dengan harga pada Q2 di 370, jadi ini
kesempatan beli murah disaat Valuasi membaik.

Net profit:
- Q1 vs Q2 vs Q3 = 64 vs 34 vs 146 , Net profit mulai kembali normal.

- ROE dan ROA naik tapi Asset dan Equity masih belum efisien terhadap laba dibanding
emiten CPO lainnya
- Ratio laba terhadap penjualan mulai normal dibanding emiten sejenis kecuali Biaya
bunga yg masih besar.


Selengkapnya:

UNSP Date : 16-11-10
Financial Performance (in billion Rp)
www.investdata.net

2010 2009| 2008|
16-11-10 ....Q3 ....Q2 ....Q1|....Q4 ....Q3 ....Q2 ....Q1|....Q4|
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------
Sales 1.896 1.134 552 2.325 1.641 1.041 459 2.931
COGS 1.113 680 333 1.652 1.167 726 313 1.909
Gross Marg 782 453 219 672 474 315 146 1.022
GM (%) 41 39 39 28 28 30 31 34
Opr Profit 567 332 151| 470 351 241 107| 759
OP (%) 29 29 27 20 21 23 23 25
Net Profit 245 99 64| 252 238 135 -129| 173
NP (%) 12 8 11 10 14 12 -28 5
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------
Stk Price 360 340 370 495| 580 870 690 310| 260
Book Value 583 573 802| 704 701 674 619| 652
PBV 0,62 0,58 0,65 0,62| 0,82 1,24 1,02 0,50| 0,40
DER 0,95 1,05 0,64| 0,90 0,93 0,96 1,03| 0,90
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------
ROE (%) 4 2 3| 9 11 10 -22| 7
ROE (Qtr) 7 1 3 2 15 41 -22 -45
ROA (%) 2 1 2| 4 6 5 -10| 3
Opr prof/share 42 25 15| 124 92 63 28| 200
EPS 18 7 6| 66 62 35 -34| 45
EPS (Qtr) 11 2 6| 3 27 70 -34| -73
EPS (Annu) 24 14 27| 66 83 71 -137| 45
PER 14,58 13,77 24,71 18,19| 8,69 10,37 9,67 -2,26| 5,67
PER (Qtr) 8,15 7,70 35,28 18,19| 37,96 7,99 2,46 -2,26| -0,89
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------
COP (year) 6,30 5,95 7,36 7,74 4,67 7,04 5,42 2,72 1,30
CLOP(year) 15,98 15,63 19,30 15,79 9,78 12,31 10,50 8,31 4,23
CLOP(Qtr) 12,86 12,58 17,70 15,79 9,66 13,09 9,50 8,31 5,12
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------
Sales Growth(%) 15 8 20 -20
Op.Prof Growth(%) 61 37 40 -38
Net.Prof/EPS Grow 2 -26 -149 45
PEG (<1) 4,69 -0,93 -0,12| 0,19
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------
Sales(Qtr) 761 581 552 683 599 582 459 539
COGS (Qtr) 432 346 333 485 441 413 313 350
Gross Marg(Qtr) 329 234 219 198 158 169 146 189
GM (%) 43 40 39 29 26 29 31 35
OP.PR (Qtr) 235 181 151 119 110 133 107 157
OP % 30 31 27 17 18 22 23 29
NET.PR (Qtr) 146 34 64 14 103 265 -129 -278
NP % 19 5 11 2 17 45 -28 -51
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------
Asset 15.063 15.531 12.463| 5.071 5.127 5.006 4.754| 4.700
Liability 7.332 7.940 4.869| 2.401 2.471 2.452 2.409| 2.230
Equity 7.731 7.590 7.594| 2.669 2.655 2.553 2.345| 2.470
Capitalis. 4.767 4.502 4.899 4.686| 2.197 3.295 2.613 1.174| 984
Share(mil) 13.242 13.242 9.467 3.788 3.788 3.788 3.788 3.788
---------- ------ ------ ------ ====== ------ ------ ------ ====== ------

See ERROR and OMISSION
- http://www.investdata.net/QQCUNSP.TXT

Date: 16-11-10 FINANCIAL RATIO COMPARISON
Sector: CPO
Ranked by: ROE
www.investdata.net

|-- ---- ------- --- --- --- ---- ---- --- ---------- ===--------- ===------ --------- ----------- ----------- ----- ------ --------
| | | |(1) (2) (3)| (4) (5)|(6)| (7) | (10) | (8) | (9) |(11)(12)(13|(14)(15)(16| (17)| (18) | MARKET|
| | | SALES |GRS OPR NET| |ROA| ROE | PER | COP | CLOP |YoY GROWTH |Q3/Q2 GROWT| | LAST | CAP. |
|NO|STOC|bio Rp |MAR PRF PRF| PBV DER| | |*LAST*| | | | OPR NET| OPR NET| PEG |PRICE |bio Rp |
| | |mio USD| % % % | | | Q2 Q3|QUARTR|TDY Q3 Q2|TDY Q3 Q2|TDY Q3 Q2|SAL PRF PRF|SAL PRF PRF| | |mio Usd|
|-- ---- ------- === === === ==== ==== === === ---****** --- -- -- === -- -- === -- -- --- --- === --- *** *** =====|======|=======|
| 1 AALI 5.721| 38 31 21| 5,8| 0,2| 19| 20 24|35 16|24| 19 23|16| 13 15|17| 14 16| 4 -6| -1| 16 62| 62|**,**|25.000| 39.368|
| 2 LSIP 2.403| 48 36 26| 3,7| 0,3| 15| 21 20|21 17|18| 15 13|13| 11 9|14| 12 10| 5 25| 31| -5 -12|-10| 0,59|11.700| 15.795|
| 3 SGRO 1.369| 35 26 18| 3,0| 0,3| 13| 14 17|24 12|17| 15 16|12| 10 11|13| 11 12| 15 9| 21| 40 34| 33| 0,81| 3.100| 5.859|
| 4 GZCO 291| 40 33 34| 1,8| 0,8| 6| 8 12|20 8|15| 13 19|16| 14 21|23| 21 34| -4 9|-21| 69 313|229|-0,73| 415| 2.075|
| 5 UNSP 1.896| 41 29 12| 0,6| 0,9| 2| 2 4| 7 8|14| 13 24| 6| 5 7|15| 15 19| 15 61| 2| 31 29|320| 4,97| 360| 4.767|
|-- ---- ------- === === === ==== ==== === === --- ====== -- -- -- === -- -- === -- -- --- --- === --- --- === =====|======|=======|

1. GRS MRG: Gross Margin to Sales (in %)
2. OPR PRF: Operating Profit to Sales (in %)
3. NET PRF: Net Profit to Sales (in %)
4. PBV: Stock Price to Book value
5. DER: Debt Equity Ratio
6. ROA: Return On Asset (in %)
7. ROE: Return On Equity (in %)
QTR: ROE Quartely, using Most Recent Quarter's Net Profit
8. COP: Capitalisation to Operating Profit (in years)
9. CLOP: Capitalisation + Liability to Operating profit (in years)
10. PER: Price Earning Ratio
QTR: PER using Most Recent Quarter's Net Profit
11. Sales Growth in % (Year on Year comparison)
12. Operating Profit Growth in % (YOY comparison)
13. Net Profit Growth in % - (YOY comparison)
14. Sales Growth in % - (Most Recent Quarter comparison)
15. Operating Profit Growth in % - (MRQ comparison)
16. Net Profit Growth in % - (MRQ comparison)
17. PEG = PER / Net Profit Growth
- http://www.investdata.net/QZA3CPO6.TXT

Sorry ada kesalahan data karena buru2, embah ulang lagi:

Performance UNSP pada Q3 jauh lebih baik dibanding Q2.

Operating profit membaik:
- Q1 vs Q2 vs Q3 = 151 vs 181 vs 235
- Akibatnya ratio CLOP membaik dari 19,3 pada Q2 menjadi 15,98
- dan PER turun dari 24,7 pada Q2 menjadi 14,58 saat ini

Net profit:
- Q1 vs Q2 vs Q3 = 64 vs 34 vs 146 , Net profit mulai kembali normal.

- ROE dan ROA naik tapi Asset dan Equity masih belum efisien terhadap laba dibanding
emiten CPO lainnya
- Ratio laba terhadap penjualan mulai normal dibanding emiten sejenis kecuali Biaya
bunga yg masih besar.

Selengkapnya:

- http://www.investdata.net/QQCUNSP.TXT
- http://www.investdata.net/QZA3CPO6.TXT

Ada kesalahan Data entry jumlah saham jadi Coba liat Posting yg sudah dikoreksi...